ASPET Members Impacting the Greater Good. In honor of Black History Month, we had the wonderful opportunity to chat with three ASPET members about their distinguished careers, their thoughts on the recent changes in funding and its effects on the future of pharmacology, and the impact of the scientific community on their lives.
I would like to thank the ASPET Washington Fellows for inspiring me. Like many people, I’ve been feeling a little cynical about politics recently, and discouraged about the current state of the union in the USA.
ASPET Executive Officer Dave Jackson reflects on the impact of the passage of the FY2026 appropriations bill on scientific research, and how that funding decision was influenced by advocacy. He also emphasizes that the fight to support scientific research continues and encourages members to continue being a part of ASPET’s advocacy efforts.
The Results are In! Congratulations to the following ASPET members who have been elected to serve as officers and division chairs, and will start their terms on July 1, 2026. And thank you to everyone who used this opportunity to cast a ballot for the future of the Society.
Dr. Reuben Named Inaugural Senior Associate Provost at Texas Southern University; ASPET Welcomes New Members.
The IDEA Faculty Scholars program concluded in February 2025, so we are taking this opportunity to check back in with the participants. This program, launched by Dr. Ashim Malhotra in coordination with ASPET’s Director of Education Catherine Fry, PhD, was created as a multi-module program to incorporate the principles of IDEA (Inclusion, Diversity, Equity and Accessibility) into pharmacology education and training. Thirteen ASPET members were selected through a competitive application process and began their training in the fall of 2024. The program consisted of a series of four workshops.
It is our honor to announce this distinguished group for the 2026 Scientific Achievement Award, Division-Sponsored Awards, and Journal Award winners who are being recognized for their excellence in the pharmacology field.
A “Dose” of Clarity. Misinformation surrounding medications can have serious consequences for patient care and individual well-being. It perpetuates stigma and distrust around medication use, often delaying treatment initiation and reducing adherence for those who could benefit most.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
